Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective review.
Sood S, Rimke A, Rankin BD, Abduelmula A, Georgakopoulos JR, Maliyar K, Bagit A, Leung F, Devani AR, Vender R, Yeung J, Prajapati VH. Sood S, et al. Among authors: bagit a. J Am Acad Dermatol. 2025 Jan 20:S0190-9622(25)00006-4. doi: 10.1016/j.jaad.2024.12.034. Online ahead of print. J Am Acad Dermatol. 2025. PMID: 39831882 No abstract available.
Biologic Treatment Outcomes in Refractory Chronic Urticaria: A Systematic Review.
Rijal H, Sood S, Bagit A, Maliyar K, Abduelmula A, Georgakopoulos JR, Mufti A, Yeung J. Rijal H, et al. Among authors: bagit a. J Cutan Med Surg. 2024 Oct 24:12034754241291869. doi: 10.1177/12034754241291869. Online ahead of print. J Cutan Med Surg. 2024. PMID: 39445598 No abstract available.
Effectiveness and safety of risankizumab dose optimization in adult patients with plaque psoriasis: An international multicentre retrospective cohort study.
Bagit A, Maliyar K, Mansour M, Georgakopoulos JR, Rankin B, Lytvyn Y, Zaaroura H, Park YJ, Wang E, Mufti A, Torres T, Le AM, Vender R, Prajapati VH, Yeung J. Bagit A, et al. J Eur Acad Dermatol Venereol. 2024 Oct 15. doi: 10.1111/jdv.20373. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39403817 No abstract available.
Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based review.
Sood S, Varenbut J, Bagit A, Perlmutter J, Maliyar K, Sachdeva M, Abduelmula A, Georgakopoulos JR, Mufti A, Prajapati VH, Yeung J. Sood S, et al. Among authors: bagit a. J Am Acad Dermatol. 2025 Jan;92(1):135-137. doi: 10.1016/j.jaad.2024.08.066. Epub 2024 Sep 16. J Am Acad Dermatol. 2025. PMID: 39293573 Free article. No abstract available.
Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort Study.
Bagit A, Maliyar K, Mansour M, Georgakopoulos JR, Rankin BD, Lytvyn Y, Zaaroura H, Park YJ, Wang OJE, Mufti A, Torres T, Le AM, Vender R, Prajapati VH, Yeung J. Bagit A, et al. J Cutan Med Surg. 2024 Nov-Dec;28(6):604-605. doi: 10.1177/12034754241274300. Epub 2024 Sep 3. J Cutan Med Surg. 2024. PMID: 39225249 No abstract available.
Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 16-week multicenter retrospective review.
Sood S, Rimke A, Rankin BD, Abduelmula A, Georgakopoulos JR, Maliyar K, Bagit A, Leung F, Devani AR, Vender R, Yeung J, Prajapati VH. Sood S, et al. Among authors: bagit a. J Am Acad Dermatol. 2024 Dec;91(6):1265-1267. doi: 10.1016/j.jaad.2024.07.1515. Epub 2024 Aug 23. J Am Acad Dermatol. 2024. PMID: 39182686 Free article. No abstract available.
32 results